First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland

Colin R Simpson, Ting Shi, Eleftheria Vasileiou, Srinivasa Vittal Katikireddi, Steven Kerr, Emily Moore, Colin McCowan, Utkarsh Agrawal, Syed Ahmar Shah, Lewis D Ritchie, Josie Murray, Jiafeng Pan, Declan T. Bradley, Sarah J E Stock, Rachael Wood, Antony Chuter, Jillian Beggs, Helen R Stagg, Mark Joy, Ruby S. M. TsangSimon de Lusignan, F D Richard Hobbs, Ronan Lyons, Fatemeh Torabi, Stuart Bedston, Maureen O'Leary, Ashley Akbari, Jim McMenamin, Chris Robertson, Aziz Sheikh

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds